HONG KONG (Reuters) - A vaccine to prevent cervical cancer, triggered by the
human papillomavirus (HPV), has helped reduce the number of teenage girls developing abnormalities in their cervix by as much as 50 percent in a study in Australia, researchers reported on Friday.